✦ LIBER ✦

3-(1 H -Indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A Agonists That Demonstrate Oral Activity as Satiety Agents

✍ Scribed by Henke, Brad R.; Willson, Timothy M.; Sugg, Elizabeth E.; Croom, Dallas K.; Dougherty,, Robert W.; Queen, Kennedy L.; Birkemo, Larry S.; Ervin, Gregory N.; Grizzle, Mary K.; Johnson, Michael F.; James, Michael K.

Book ID: 127223546
Publisher: American Chemical Society
Year: 1996
Tongue: English
Weight: 138 KB
Volume: 39
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm960249k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimization of 3-(1 H -Indazol-3-ylmeth

Optimization of 3-(1 H -Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists

✍ Henke, Brad R.; Aquino, Christopher J.; Birkemo, Larry S.; Croom, Dallas K.; Dou 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 613 KB

ChemInform Abstract: 3-(2-(N-Phenylaceta

ChemInform Abstract: 3-(2-(N-Phenylacetamide))-1,5-benzodiazepines: Orally Active, Binding Selective CCK-A Agonists.

✍ T. M. WILLSON; B. R. HENKE; T. M. MOMTAHEN; P. L. MYERS; E. E. SUGG; R. J. UNWAL 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB

Discovery of N-benzyl-2-[(4S)-4-(1H-indo

Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity

✍ Richard L. Elliott; Kimberly O. Cameron; Janice E. Chin; Jeremy A. Bartlett; Ele 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 598 KB

We describe the design, synthesis, and structure-activity relationships of triazolobenzodiazepinone CCK1 receptor agonists. Analogs in this series demonstrate potent agonist activity as measured by in vitro and in vivo assays for CCK1 agonism. Our efforts resulted in the identification of compound 4

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

(3 R )- N -(1-( tert -Butylcarbonylmethy

(3 R )- N -(1-( tert -Butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1 H - 1,4-benzodiazepin-3-yl)- N ‘-(3-(methylamino)phenyl)urea (YF476): A Potent and Orally Active Gastrin/CCK-B Antagonist

✍ Semple, Graeme; Ryder, Hamish; Rooker, David P.; Batt, Andrzej R.; Kendrick, Dav 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 304 KB

ChemInform Abstract: (3R)-N-(1-(tert-But

ChemInform Abstract: (3R)-N-(1-(tert-Butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)- 1H-1,4-benzodiazepin-3-yl)-N′-(3(methylamino)phenyl)urea (YF476): A Potent and Orally Active Gastrin/CCK-B Antagonist.

✍ G. SEMPLE; H. RYDER; D. P. ROOKER; A. R. BATT; D. A. KENDRICK; M. SZELKE; M. OHT 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 1 views